Ceterix Orthopaedics wins FDA 510(k) clearance for NovoStitch Plus
Submitted by kBLASTER Team on
by Fink Densford for MassDevice.com
Ceterix Orthopaedics said today it won FDA 510(k) clearance for its NovoStitch Plus meniscal repair system designed for patients with meniscal tearing.
The device is a next-generation version of the company’s NovoStitch, designed to treat a variety of different meniscal tears, the Menlo Park, Calif.-based company said.
“The main difference is the NovoStitch Plus has a cartridge-based system and the cartridge has an...